Notice of Meeting of members by way of postal ballot commencing from December 04, 2025 to January 03, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals Ltd has issued a postal ballot notice seeking shareholder approval via special resolution to continue Mr. Jitendra Somchand Shah (DIN: 01609325) as a Non-Executive Independent Director beyond the age of 75. Mr. Shah, who turned 75 on September 22, 2025, was originally appointed in July 2024 for a five-year term ending at the 36th AGM. Under SEBI's Listing Regulations (Regulation 17(1A)), shareholder approval is mandatory for any independent director continuing past age 75. The e-voting window runs from December 4, 2025 (9:00 AM) to January 3, 2026 (5:00 PM), with results expected on or before January 5, 2026. The company cited Mr. Shah's 42+ years of experience in marketing, corporate sales, and business development as justification for his continuation. The cut-off date for determining voting eligibility is November 21, 2025.
This is a routine regulatory compliance filing and is unlikely to materially impact the stock price. The resolution is procedural and typically approved without controversy, though rejection would create a board vacancy requiring a new appointment.